Korea University College of Medicine selected as the lead institution for hantavirus vaccine development project
The two-year project will use domestic mRNA technologies to build a vaccine platform that can produce prototypes within 200 days of a future pandemic.
2 Articles
2 Articles
Korea University College of Medicine selected as the lead institution for hantavirus vaccine development project
The Vaccine Innovation Center at Korea University College of Medicine has been selected by the Korea Disease Control and Prevention Agency (KDCA) as the lead institution for a national hantavirus vaccine development project.
New sa‑mRNA and LNP Platform to Support Korea’s Hantavirus Vaccine Initiative
With hantavirus thrust into the public spotlight in recent months, a new effort in South Korea aims to advance vaccine development against the rodent-borne pathogen using mRNA technologies. Korea University College of Medicine has been selected to lead a government-supported initiative focused on developing next-generation hantavirus vaccines. The program will be conducted through the institution’s Vaccine Innovation Center. Hantaviruses are car…
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium

